MedPath

LEVOSIMENDAN KALCEKS 2,5 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION EFG

LEVOSIMENDAN KALCEKS 2,5 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION EFG

Pending
Register Number

86702

Prescription Type

Uso Hospitalario

Authorization Date

Mar 28, 2022

Dosage Form

CONCENTRADO PARA SOLUCIÓN PARA PERFUSIÓN

Route: VÍA INTRAVENOSA

Product Details

Detailed information about this CIMA AEMPS approved pharmaceutical product.

Basic Information

Key regulatory and product classification details

Regulatory Details

Register Number86702
EMA Approved
No

Drug Classification

Generic
Yes
Orphan
No
Biosimilar
No
Commercialized
No
CIMA AEMPS Classification

INGREDIENTS (1)

LEVOSIMENDANActive
Quantity: 2,5 mg
Name: LEVOSIMENDAN

ATC CLASSIFICATION (3)

C01C
C01CX
C01CX08

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.